Qingying Yu

Qingying Yu

Auto-generated profile, based on publicly available information

Qingying Yu

State Key Laboratory of Traditional Chinese Medicine Syndrome, International Institute for Translational Chinese Medicine, School of Pharmaceutical Science, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2024 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
YXYing Xiong
Ying Xiong
QYQingying Yu
Qingying Yu
HZHaimei Zhi
Haimei Zhi
HPHuiyuan Peng
Huiyuan Peng
MXMingjun Xie
Mingjun Xie
PSPeng Sun
Peng Sun
The glymphatic system is cerebrospinal fluid–brain tissue fluid exchange flow mediated by aquaporin‐4 (AQP4) on the end feet of astrocytes for a system, which is capable of rapidly removing brain metabolites and thus maintaining brain homeostasis, and is known as the central immune system. Dysfunction of the glymphatic system causes accumulation of misfolded and highly phosphorylated proteins (amyloid‐β and Tau proteins), which destabilizes the proteins, and the body's neuroinflammatory factors are altered causing aging of the immune system and leading to neurodegenerative diseases. Damage to the glymphatic system and aging share common manifestations, as well as unstudied biological mechanisms that are also linked, such as mitochondria, oxidative stress, chronic inflammation, and sleep. In this paper, we first summarize the structure, function, and research methods of the glymphatic system and the relationship between the glymphatic system and the peripheral immune system, and second, sort out and summarize the factors of the glymphatic system in removing metabolites and resolving aging‐related diseases and factors affecting aging, to explore its related biological mechanisms, and moreover, to provide a new way of thinking for treating or intervening aging‐related diseases.

24 March 2025 in Food & Function
Verified
Journal Article
Closed access
PDF file
QYQingying Yu
Qingying Yu
HLHuan Li
Huan Li
MCMengxue Chen
Mengxue Chen
YPYanan Pan
Yanan Pan
LZLiuchang Zhou
Liuchang Zhou
DDDi Deng
Di Deng
EPA improve depressive-like behaviour by ameliorating neuroinflammation and modulating synaptic plasticity via GPR120.